-
mindsON RBQM | Episode 15: The Risk Assessment is easy, right? Wrong! (Webinar | Online)
Language: English Time: 17.00 to 18.30 h (German time zone, CET) Price: 0 € (free of charge) Webinar: Describe and discuss the practical challenges with risk assessment. How many risks should you have? Should risks that are for multiple studies be included? Should you only include risks that are study specific? Should the impact score be based on the impact of the whole study or individual patients? What is a „mindsON RBQM workshop“? mindsON RBQM is a series of workshops that provides practical advice on the challenging aspects of an RBQM roll-out and its daily execution, performed by Cyntegrity Germany GmbH – the holistic RBQM solution provider. Each workshop allows…
Das könnte dich ebenfalls interessieren
CREATE – Das Netzwerk für nachwachsende Rohstoffe in der Kunststoffbranche stellt sich vor (Webinar | Online)
Einführung in SXIVE – Ein softISP-basiertes System für Rapid Imaging Prototyping (Webinar | Online)
BRANDABSCHOTTUNGEN UND IHRE STÜTZKONSTRUKTIONEN (Webinar | Online)
-
mindsON RBQM | Episode 14: QTLs – The Return! (Webinar | Online)
Language: English Time: 17.00 to 18.30 h (German time zone, CET) Price: 0 € (free of charge) Webinar: We ran a workshop on QTLs in 2022 and were inundated with questions. So we thought we needed to return to the subject! We will explore the latest thinking on QTLs, discuss why organizations find them so challenging to implement, suggest practical approaches, and have plenty of opportunity for lots more of your questions. What is a „mindsON RBQM workshop“? mindsON RBQM is a series of workshops that provides practical advice on the challenging aspects of an RBQM roll-out and its daily execution, performed by Cyntegrity Germany GmbH – the holistic RBQM…
-
mindsON Global Risk Management | How Ukraine-based CRO adopts war as opportunity (Webinar | Online)
A War – A Low Probability Risk with High Impact In this special episode of mindsON Global Risk Management, our CEO, Artem Andrianov, Ph.D., speaks with Dr. Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Ukraine, that works with BioPharma and Medical Device companies across the globe. As a data science organization that is entirely focused on de-risking clinical trials and their conduct, tackling the unique set of risks that have low probability but have high, often global impact, is an objective that has been on our minds since the COVID-19 outbreak. What if we could predict and mitigate global threats such as pandemics, wars, and…
